Connect with us

Published

on

Weight loss has always been big business, but it’s exploded of late due to surging demand for Ozempic, Wegovy and other new diabetes and obesity drugs.

In the first half of 2023, sales of Ozempic and Wegovy rose by 58% and 363%, respectively. That’s after quarterly prescriptions for those types of GLP-1 treatments, which mimic a hormone in the gut to suppress a person’s appetite, increased 300% between early 2020 and the end of last year.

But as consumers and businesses pour more money and resources into tackling the obesity epidemic, which costs the U.S. more than $170 billion a year, drug developers aren’t alone in coming up with innovative solutions.

Signos, a five-year-old startup, is taking an approach that doesn’t involve pills.

The company is using off-the-shelf continuous glucose monitors, or CGMs, and providing real-time diet and exercise recommendations based on an individual’s readings. CGMs are small sensors worn on the upper arm that track glucose levels, primarily for people with diabetes. The information is wirelessly sent to a smartphone, allowing the user to better prevent emergencies.

Signos uses CGMs built by Dexcom. The startup has its own app that shows users how their body responds to specific foods, what causes their glucose to spike and when they should exercise to get the best results for weight loss.

On Tuesday, Signos said it closed a $20 million funding round led by Cheyenne Ventures and GV, formerly known as Google Ventures. Dexcom Ventures also contributed to the financing. Signos said it will use the fresh capital to continue its research into metabolic health and to expand its team, which is currently around 45 people.

“Whether you have five pounds to lose or 100, we want to make sure we’re able to help everybody,” Sharam Fouladgar-Mercer, Signos’ co-founder and CEO, told CNBC in an interview. 

Customers who sign up for Signos can choose a one-month, three-month or six-month plan. With the half-year plan, users pay $143 a month, which includes all of the pricey CGMs they’ll need during that time. The company declined to share specific details about how many people are currently using its platform.

Fouladgar-Mercer said the long timelines are designed to attract users who are serious about their weight-loss journey. Additionally, the sensors themselves have a long wear time. The Dexcom G6 and G7, the latest devices, can measure glucose for up to 10 days. Signos currently supports the G6 and will soon work with the G7 as well.

Fouladgar-Mercer said Signos is using Dexcom’s CGMs as part of a clinical study approved by an institutional review board designated by the U.S. Food and Drug Administration to monitor biomedical research involving real people. 

Fouladgar-Mercer said he created the company in 2018 partly because of his own struggle to manage weight throughout his life. He trained as an athlete and played hockey in college, but he said he noticed how food often affected him differently from the way it affected his teammates.

He said he always felt that, in an effort to understand an individual’s metabolism, there was a “critical component” missing, and it had been nagging at him for 30 years.

Signos helps users understand the right decision to make in the moment, but they can go “behind the scenes” and learn as much about the science as they’d like, Fouladgar-Mercer said. Users can also integrate sleep data, heart rate data, and exercise data from their Apple Watch to personalize their profile even more. 

“Once they trust the system works and they understand the methodology, they can just follow the really quick, here’s what I do, here’s what I do, here’s what I do,” Fouladgar-Mercer said. “And that’s how you get behavioral change.”

Though Dexcom primarily develops its CGMs for patients with diabetes, the company is also working toward broader applications. For instance, next year it’s releasing a new product meant for people who aren’t taking insulin. Similarly, Abbott Laboratories, which dominates the global CGM market, is hoping to bring its first consumer-facing CGM, called Lingo, to the U.S. next year, adding personalized coaching with recommendations about diet, sleep and exercise.

Fouladgar-Mercer said Signos has more data points than “anybody does in the world for non-diabetics.” He added that since the company built its first product almost five years ago, it’s been able to focus on fine-tuning its technology. 

“I don’t want to incorrectly set expectations,” Fouladgar-Mercer said. “I think a lot of times, it’s like, ‘Oh, lost X pounds in X days.’ That’s not what we’re trying to accomplish. It’s really, how do we put you on a sustainable journey? And that journey is not going to be done in two or three days.”

Fouladgar-Mercer said Signos can work well alongside Ozempic and Wegovy from Novo Nordisk and other GLP-1 treatments. Novo Nordisk’s share price has quadrupled since 2018, and the company is now the most valuable in Europe.  

Fouladgar-Mercer said GLP-1 drugs are a “powerful tool” that can help people jump-start weight loss, but it can be challenging to keep weight off if they stop taking the medication. Platforms such as Signos can help to reinforce and maintain a healthier lifestyle over time, he said.

Ultimately, he said, he wants people to use Signos to learn how to make better choices that work best for their bodies. 

Signos, Fouladgar-Mercer said, can use technology and data “to drive behavioral change, and then wrap that all in a system that really is focused on driving and solving this biggest problem we have in America, which is weight.”

WATCH: Novo Nordisk stops Ozempic trial early after signs of success

Continue Reading

Technology

CNBC Daily Open: A murky past and uncertain future trouble traders

Published

on

By

CNBC Daily Open: A murky past and uncertain future trouble traders

Traders work on the floor of the New York Stock Exchange (NYSE) on Nov. 13, 2025 in New York City.

Spencer Platt | Getty Images

U.S. markets had their worst day since Oct. 10. That marks a sharp reversal for the Dow Jones Industrial Average, which shed 1.65% to settle at 47,457.22, a day after it closed above 48,000 for the first time. Meanwhile, the S&P 500 lost 1.66% and the Nasdaq Composite tumbled 2.29%.

The slump in stocks can partly be traced to a turnaround in sentiment regarding artificial intelligence. Tech behemoths such as Nvidia, Broadcom and Oracle slumped, with the last losing more than one-third in value since it rocketed 36% in September.

Investors, it seems, are growing worried over the high valuations of tech names, as well as the gigantic amount of capital expenditure they are committing to — with some, like Oracle, having to take on debt to fulfil those obligations.

Uncertainty over an interest rate cut in December is also putting a downer on Wall Street. It’s a coin toss as to whether the U.S. Federal Reserve will ease monetary policy then, according to the CME FedWatch tool. That’s a huge difference from a month ago, when traders were pricing in a 95.5% chance of a December cut.

Not having October’s employment and inflation numbers, and possibly never getting them, means the Fed lacks visibility into the state of the economy — and whether it should try to support the labor market or continue reining in inflation.

After all, flying blind makes it hard to see where you’ll land. As of now, that applies both to the Fed and investors trying to navigate the still-hazy ambitions of tech companies.

What you need to know today

And finally…

Tan Su Shan, chief executive officer of DBS Group Holdings Ltd., speaking at the Singapore Fintech Festival in Singapore, on Nov. 12, 2025.

Bloomberg | Bloomberg | Getty Images

CEO of Southeast Asia’s largest bank says AI adoption already paying off: ‘It’s not hope, it’s now’

“The proliferation of generative AI has been transformative for us,” DBS CEO Tan Su Shan told CNBC on the sidelines of Singapore Fintech Week. She adding that the company was experiencing a “snowballing effect” of benefits thanks to machine learning. 

Tan expects AI adoption to bring DBS an overall revenue bump of more than 1 billion Singapore dollars (about $768 million) this year, compared to SG$750 million in 2024. That assessment is based on about 370 AI use cases powered by over 1,500 models throughout its business. 

— Dylan Butts

Continue Reading

Technology

‘Vibe revenue’: AI companies admit they’re worried about a bubble

Published

on

By

‘Vibe revenue’: AI companies admit they’re worried about a bubble

Eakarat Buanoi | Istock | Getty Images

LISBON, Portugal — Top tech executives told CNBC they’re concerned about a bubble forming in the artificial intelligence sector, underscoring growing unease within the industry over soaring valuation.

In recent weeks, markets have been reckoning with the notion that too much capital is pouring into the AI boom, clouding the outlook on revenue and actual profit and putting high valuations into question.

Up to now, warnings around overstretched valuations have mostly come from investors and leaders in the world of finance. Goldman Sachs’ David Solomon and Morgan Stanley’s Ted Pick have warned of potential corrections as valuations of some major tech firms reached historic highs.

The concerns have been crystallized by famed ‘Big Short’ investor Michael Burry, who this week accused major AI infrastructure and cloud providers, or ‘hyperscalers’ of understating depreciation expenses on chips. Burry warned that profits at the likes of Oracle and Meta may be vastly overstated. He recently disclosed put options that bet against Nvidia and Palantir.

However, CEOs of companies who are themselves developing AI, expressed their concerns this week during interviews with CNBC at the Web Summit tech conference in Lisbon.

“I think the evaluations are pretty exaggerated here and there, and I think there is signs of a bubble on the horizon,” Jarek Kutylowski, CEO of German AI firm DeepL, told CNBC on Tuesday.

DeepL CEO: Signs of AI bubble on the horizon

The sentiment was echoed by Picsart CEO Hovhannes Avoyan.

“We see lots of AI companies raising … tremendous valuations … without any revenue,” Avoyan told CNBC on Tuesday, adding that it is a “concern.”

The market values smaller startups with “just some noise and vibe revenue,” he said, referring to companies being backed even though they have minimal sales.

Vibe revenue is a play on “vibe coding,” a term that refers to using AI to code without needing deep technical expertise.

AI demand growing

Even with concerns over valuations, the technology industry remains bullish on the long term potential of AI.

Lyft CEO David Risher said there are reasons to be optimistic given the potential impact of AI but acknowledged the risks.

“Let’s be clear, we are absolutely in a financial bubble. There is no question, right? Because this is incredible, transformational technology. No one wants to be left behind.”

Risher went on to argue that there is a difference between the financial bubble and the industrial outlook.

“The data centers and all the model creation, all of that is going to have a long, long life, because it’s transformational. It makes people’s lives easier. It makes people’s lives better… On the other hand, you know, the financial side, it’s a little risky right now.”

The tech CEOs also addressed their outlook on AI demand for 2026 from businesses, as investors look for any clues as to what this will look like.

“I think there’s a lot of demand, and there’s a lot of interest. I think everybody understands that AI can do magical things to businesses, and… we can all operate on another level when it comes to efficiency,” Kutylowski said.

Still, businesses are “strugging in adopting” AI. “We’re going to get further, but I don’t think we’re that we’re going to be in a place where we can say, like every enterprise, every organization, has it figured out totally,” Kutylowski said.

Picsart CEO: Market values smaller startups with vibe revenue

DeepL’s core product is an AI translation tool but it recently launched a more general purpose “agent” designed to be able to carry out tasks on behalf of employees.

Francois Chadwick, the chief financial officer of Cohere, a company that is also focused on enterprise AI, told CNBC on Tuesday that “demand is definitely there.”

$4 trillion capex outlook

Despite the concerns over overstretched valuations and huge capex spend, the investment into artificial intelligence doesn’t appear to be slowing down. A report from venture capital group Accel released this week showed that the buildout of new AI data center capacity is forecast to reach 117 gigawatts by 2030 which translates into about $4 trillion worth of capital expenditure over the next 5 years.

About $3.1 trillion worth of revenue is required to pay back that capex, according to the Accel report.

Already this year, there have been a slew of deals worth billions announced by the likes of Nvidia and OpenAI as they look to develop data center capacity around the world in a bid to keep up with demand.

Philippe Botteri, a partner at Accel, said that three major factors will drive that revenue — more powerful AI models that require capacity to be trained, the use of new AI services and the “agentic revolution in the enterprise.”

“Agentic” is often a term used to describe a type of AI tool that can automatically carry out tasks on behalf of users.

Probably over-exuberance around data centers, says investor

But not everyone believes that the large amount of spending is necessary.

Ben Harburg, managing partner at Novo Capital says the figures being discussed by large tech firms for future investment may be overblown.

“We hear these crazy headline numbers about how much energy is going to be needed, how many chips are going to be needed, although, again, I think that there is probably more of a bubble brewing there than on kind of the front end, the actual product front,” Harburg told CNBC on Tuesday.

“I think we’re starting to realize that there’s been probably over exuberance around data centers. Even Sam [Altman], I think, would privately admit that they need fewer chips than they originally set out, they need less capital than they originally set out. They need less energy than they originally set out.”

Continue Reading

Technology

CEO of Southeast Asia’s largest bank says AI adoption already paying off: ‘It’s not hope, it’s now’

Published

on

By

CEO of Southeast Asia's largest bank says AI adoption already paying off: ‘It’s not hope, it’s now’

Tan Su Shan, chief executive officer of DBS Group Holdings Ltd., speaking at the Singapore Fintech Festival in Singapore, on Nov. 12, 2025.

Bloomberg | Bloomberg | Getty Images

SINGAPORE – Amid fears of an artificial intelligence bubble, much has been made of recent reports suggesting that AI has yet to generate returns for companies investing billions into adopting the tech. 

But that’s not what the chief executive of Southeast Asia’s largest bank is seeing — she says her firm is already reaping the rewards of its AI initiatives, and it’s only just the beginning. 

“It’s not hope. It’s now. It’s already happening. And it will get even better,” DBS CEO Tan Su Shan told CNBC  on the sidelines of Singapore Fintech Week, when asked about the promise of AI adoption.  

DBS has been working to implement artificial intelligence across its bank for over a decade, which helped prepare its internal data analytics for recent waves of generative and agentic AI. 

Agentic AI is a type of artificial intelligence that relies on data to proactively make independent decisions, plan and execute tasks autonomously, with minimal human oversight.

Tan expects AI adoption to bring DBS an overall revenue bump of more than 1 billion Singapore dollars (about $768 million) this year, compared to SG$750 million in 2024. That assessment is based on about 370 AI use cases powered by over 1,500 models throughout its business. 

“The proliferation of generative AI has been transformative for us,” Tan said, adding that the company was experiencing a “snowballing effect” of benefits thanks to machine learning. 

A major area in which DBS has applied AI is in its financial services to institutional clients, with AI used to collect and leverage data for clients in order to better contextualize and personalize offerings. 

According to Tan, this has resulted in “faster and more resilient” teams. The CEO believes that these uses of AI have contributed to a recent uptick in the bank’s deposit growth as compared to competitors’.

The company also recently launched a newly enhanced AI-powered assistant for corporate clients known as “DBS Joy,” which assists clients with unique corporate banking queries around the clock. 

ROI concerns 

Despite Tan’s strong convictions about AI, recent evidence suggests that many companies are struggling to turn their AI investments into tangible profits. 

MIT released a report in July that found 95% of 300 publicly disclosed AI initiatives, encompassing generative AI investments of $30–$40 billion, had failed to achieve real returns. 

However, at least in the banking sector, there are signs that the tides are turning. 

While DBS doesn’t differentiate spending in generative AI from other in-house investments, other major banks have recently offered this comparison. 

JPMorgan Chase CEO Jamie Dimon stated in an interview with Bloomberg TV last month that the bank is already breaking even on its approximately $2 billion of annual investments in AI adoption. That represents “just the tip of the iceberg,” he added.

Those expectations are shared by DBS, which plans to continue to accelerate its AI development to become an AI-powered bank.

The ultimate goal, according to Tan, is for its generative AI to develop into a trusted financial advisor for clients, including retail users who are expected to interact with personalized AI agents through the DBS banking app. 

The bank already has over 100 AI algorithms that analyze users’ data to provide them with personalized “nudges,” such as alerts on incoming shortfalls, product recommendations, and other insights. 

Continued AI investments 

While DBS may already be reaping rewards from its AI adoption, Tan acknowledged that it will require continued investments, not only in capital, but in the time needed to reskill employees. 

The company has launched several AI reskilling initiatives across departments this year and has even deployed a generative AI-powered coaching tool to support these efforts. 

This will help the company automate mundane work and refocus its staff on building and maintaining human-to-human relationships with customers, rather than reducing headcount, Tan said. 

“We’re not freezing hiring, but it does mean reskilling. And that’s a journey. It’s a never-ending journey … a constant evolution.”

Continue Reading

Trending